FdaApplication
BLA 125659
Identifiers
- fda_app_no: BLA125659
Properties
| Property | Value |
|---|---|
| applicant_name | Kedrion Biopharma Inc. |
| application_type | BLA |
| approval_date | 2021-06-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RYPLAZIM | — | 68.8MG | For Injection |
1 product